What this means
This trial plans to test whether fisetin, a natural compound, can improve blood vessel function in older adults. It also plans to check safety, and whether people keep taking it, but it has not started and has no results yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 65 and over
- Where
- 1 site, including Colorado
The science
- Registered title
- Fisetin for Improving Vascular Function in Older Adults: A Phase II Clinical Trial
- Trial ID
- NCT07871162 ↗
- Phase
- PHASE 2
- Study type
- interventional
- Conditions
- Aging, Endothelial Dysfunction, Cellular Senescence
- What is tested
- Fisetin, Placebo
- Sponsor
- University of Colorado, Boulder
- Ages
- 65 Years to no maximum
- Dates
- First posted Oct 13, 2026 · updated Oct 15, 2026
Registry summary
Aging is associated with the development of vascular dysfunction, which increases the risk for cardiovascular disease. This clinical trial will assess if supplementation with the natural compound fisetin can improve vascular endothelial function in older adults. The clinical trial will also assess if any effects of fisetin on endothelial function are associated with reduced cellular senescence. The study will also evaluate safety, tolerability and adherence with fisetin treatment.
Sites (1)
- University of Colorado Boulder, Boulder, Colorado, United States